|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0019704,
umls-concept:C0021311,
umls-concept:C0021756,
umls-concept:C0231221,
umls-concept:C0348016,
umls-concept:C0443315,
umls-concept:C1257890,
umls-concept:C1707455,
umls-concept:C2587213,
umls-concept:C2603343
|
|
pubmed:issue |
9168
|
|
pubmed:dateCreated |
1999-7-8
|
|
pubmed:abstractText |
Intermittent interleukin-2 therapy for HIV-1 by continuous intravenous infusion leads to sustained increase of CD4 T cells. This method of administration is, however, inconvenient and has limiting toxic effects. We did a randomised study to compare safety and efficacy of antiviral treatment alone or combined with various interleukin-2 regimens in HIV-1-infected patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
pubmed-author:AboulkerJ PJP,
pubmed-author:BoumsellLL,
pubmed-author:CapitantCC,
pubmed-author:CarrieroSS,
pubmed-author:DelfraissyJ FJF,
pubmed-author:GastautJ AJA,
pubmed-author:GomardEE,
pubmed-author:GoujardCC,
pubmed-author:GuilletJ GJG,
pubmed-author:HouhouSS,
pubmed-author:LeviII,
pubmed-author:OksenhendlerEE,
pubmed-author:RabianCC,
pubmed-author:SeligmannMM,
pubmed-author:ViardJ PJP,
pubmed-author:WeissLL
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
5
|
|
pubmed:volume |
353
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1923-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10371571-Adult,
pubmed-meshheading:10371571-Anti-HIV Agents,
pubmed-meshheading:10371571-CD4 Lymphocyte Count,
pubmed-meshheading:10371571-CD4-CD8 Ratio,
pubmed-meshheading:10371571-Didanosine,
pubmed-meshheading:10371571-Female,
pubmed-meshheading:10371571-Follow-Up Studies,
pubmed-meshheading:10371571-HIV Infections,
pubmed-meshheading:10371571-HIV-1,
pubmed-meshheading:10371571-Humans,
pubmed-meshheading:10371571-Infusions, Intravenous,
pubmed-meshheading:10371571-Injections, Subcutaneous,
pubmed-meshheading:10371571-Interleukin-2,
pubmed-meshheading:10371571-Male,
pubmed-meshheading:10371571-Time Factors,
pubmed-meshheading:10371571-Zidovudine
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group.
|
|
pubmed:affiliation |
Unité d'Immunologie clinique, Hôpital Henri Mondor, Creteil, France. yves.levy@hmn.ap-hop-paris.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
